Apple Watch Import Ban Lifted as ITC Closes Case

The US International Trade Commission (ITC) has decided to close the case involving an import ban on certain Apple Watch models, effectively ending the patent dispute with medical technology company Masimo. The dispute centered on patents related to the Apple Watch’s blood oxygen feature. Masimo had accused Apple of infringing on its patents with the Apple Watch’s ability to measure blood oxygen levels.

The ITC’s decision removes a significant overhang on Apple’s wearable device business, which includes the Apple Watch, a key contributor to Apple’s revenue. The company can now continue to import and sell the affected Apple Watch models without disruption.

The ruling does not necessarily mean that Apple has been cleared of any wrongdoing or that Masimo’s patents were not infringed. The two companies may continue to engage in negotiations to resolve their differences.

The Apple Watch has become an increasingly important product line for Apple, playing a critical role in the company’s strategy to expand its presence in the wearables market.

Updates

• 2026-08-11 — Apple Pay and Wallet leader retiring after two decades at Apple (source)
• 2026-08-03 — The Anbernic RG SP will be available on August 5 (source)
• 2026-07-30 — Apple spent a record $11.73 billion in R&D during Q3 2026 (source)
• 2026-05-30 — Meta is reportedly working on an AI pendant and more smart glasses (source)
• 2026-05-27 — Apple Wallet digital ID support expands to new state (source)
• 2026-05-14 — Desperate Trump taps “Tim Apple,” Jensen Huang, Elon Musk to attend Xi summit (source)
• 2026-05-08 — Apple’s education discount now requires proof that you’re a student (source)
• 2026-05-08 — Apple now requires verification for Education Store, adds Apple Watch with discounts (source)
• 2026-04-24 — Fitbit 4.68 rolling out sleep editing, motivational Coach messages, more personalization (source)
• 2026-04-24 — ComfyUI hits $500M valuation as creators seek more control over AI-generated media (source)